Tirzepatide Lowers Cardiovascular and Kidney Events vs Dulaglutide in High-Risk Diabetes: Study
In a new post hoc analysis, tirzepatide was associated with a lower incidence of a composite cardiovascular and kidney outcome compared with Dulaglutide in patients with diabetes and established cardiovascular…